Analytic for Hemodynamic Instability (AHI)
Adjunctive Hemodynamic Indicator With Decision Point. De Novo DEN200022, from Fifth Eye, Inc. (Ann Arbor, MI). Product code QNV, class 2.
As of Nov 19, 2026, DEN200022 is an FDA De Novo held by Fifth Eye, Inc., granted on Mar 1, 2021 after 332 days, with no recalls tied to it in FDA's recall database.
- Review time: 332 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The AHI software is intended for use by healthcare professionals managing in-hospital patients 18 years or older who are receiving continuous physiological monitoring with electrocardiography (ECG). AHI provides a frequently updated binary output over time based on pattern analysis of a lead-II ECG waveform intended to describe a patient's hemodynamic status and indicate if a patient is showing…
- Design
- Prospective, single-center, observational study of ECG and arterial-line monitored critical care patients vs. invasive BP reference standard
- Enrolled
- 222
- Where
- 1 site
- Primary endpoint
- Windows-based sensitivity and specificity for identifying out-of-range vital signs (hypotension plus tachycardia) vs. invasive BP reference
- Result
- Met: sensitivity 95.6% (2.5% LCB 88.9%, goal >85%); specificity 84.9% (1-specificity UCB 19.7%, goal <25%)
- Appraise-HriK233249 · The Surgeon General, Department of the Army (TSG-DA) · Apr 5, 2024
- AHI SystemK212219 · Fifth Eye, Inc. · Dec 3, 2021
- AHI SystemK221203 · Fifth Eye, Inc. · Jul 14, 2022
- AHI SystemK212219 · Fifth Eye, Inc. · Dec 3, 2021
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Type
- Direct
- Received
- Apr 3, 2020
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2220
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files